eGain (EGAN) Q4 2026 Earnings Call Transcript

eGain reported fiscal 2026 revenue of $91.1 million, up 3%, with AI-customer revenue rising 20%, adjusted EBITDA increasing to $13.6 million from $8.6 million, and operating cash flow reaching a record $21.2 million. However, fiscal 2027 guidance calls for total revenue of $84.5 million-$86.0 million, implying a 5.6%-7.2% decline, and adjusted EBITDA of only $0.65 million-$1.4 million as the company funds AI growth while legacy customer revenue is expected to fall 20% and legacy ARR 60%. AI customer ARR grew 13% to 72% of SaaS ARR, but total SaaS ARR declined 1%, RPO fell 5% to $87 million, and AI net retention eased to 104% from 120%. Management targets AI ARR of $100 million-$120 million by fiscal 2030 and repurchased $11.5 million of stock during fiscal 2026.

Analysis

EGAN is entering a difficult revenue-recognition valley: legacy runoff is immediate and contractual visibility is weakening, while paid pilots defer the conversion of an otherwise promising enterprise pipeline into ARR. The FY27 guide implies roughly 6%-7% revenue contraction and an EBITDA-margin reset from 15% to near breakeven; this is not simply investment spending, but a period in which operating leverage reverses before new-logo production deployments scale. The customer-level “AI” reporting also inflates perceived AI exposure because it includes non-AI spend from any account using an AI feature, making the reported AI growth rate less comparable to pure-product ARR.

The core valuation support is the net-cash balance sheet and buyback capacity, but repurchases near the current historical purchase price are a questionable capital-allocation signal if the company is about to fund materially higher sales and marketing with sharply lower profitability. Gartner category validation may improve enterprise shortlists, yet it also attracts better-capitalized adjacent competitors—ServiceNow (NOW), Salesforce (CRM), NICE (NICE), and Genesys/private vendors—whose installed bases can bundle knowledge, workflow and contact-center AI. EGAN's defensibility hinges on proving that governed knowledge reduces inference costs and error rates enough to overcome platform consolidation.

Near-term downside catalysts are the first FY27 revenue decline, further deterioration in RPO/net retention, or weak pilot-to-production conversion disclosed at the October event. A credible upside catalyst over 1-3 months would be named enterprise conversions with initial ARR above $500k and evidence that AI ARR growth is accelerating despite legacy churn. Over 6-18 months, the thesis only works if new logos can sustain growth while gross margin remains resilient; management has already flagged modest pricing pressure, leaving limited room for execution misses at this scale.

Key Decisions for Investors

• Avoid initiating a directional long before the October 13 Investor Day; the next two quarterly prints must absorb the revenue and margin trough, while the key missing KPI is paid-pilot conversion rate and average production ARR.
• For existing EGAN exposure, reduce on strength and retain only a small event-driven position. Reassess bullishly only if AI ARR growth exceeds the ~20% FY27 target, RPO returns to growth, and EBITDA guidance is maintained; a cut to AI ARR guidance or DBNR below 100% falsifies the recovery case.
• Consider a 3-6 month relative-value short EGAN versus long IGV or a basket of NOW/CRM/NICE if EGAN rallies on category enthusiasm without disclosed production conversions. The spread thesis is that incumbents monetize the same enterprise AI budget through installed-base bundling while EGAN bears standalone go-to-market costs; cover if EGAN announces multiple $500k+ ARR conversions or lifts FY27 revenue guidance.
• Monitor buyback activity as a liquidity/support signal rather than an earnings catalyst. A pause in repurchases while cash-funded investment rises would remove an important downside buffer; continued aggressive repurchases alongside falling RPO would increase balance-sheet and capital-allocation concern.